
Sundari Raviprasad Pisupati
About Sundari Raviprasad Pisupati
Data last updated:
Sundari Raviprasad Pisupati is a Director at Eugia Pharma Specialities Limited (since 2021), Director at Rainbow Children's Medicare Limited (since 2021) and Director at Rainbow Speciality Hospitals Private Limited (since 2022), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Transport and Logistics. The 3 current companies with reported revenue have a combined latest revenue of ₹6,435 Cr; the largest is Eugia Pharma Specialities Limited at ₹4,829 Cr (FY 2025). Earlier, Sundari Raviprasad Pisupati was a Director at Tran-Scell Biologics Private Limited (2009–2015) and Director at Ocean Sparkle Limited (2015–2022) and 7 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Dec 2021 | 2013 | ₹4,829 Cr (FY 2025) | Active | |
| Director | 16 Sep 2021 | 1998 | ₹1,567 Cr (FY 2025) | Active | |
| Director | 25 May 2022 | 2010 | ₹39.30 Cr (FY 2025) | Active | |
| Director | 18 Aug 2025 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Dec 2009 | 2009 | ₹1.44 Cr (FY 2025) | Active | |
| Director | 07 Aug 2015 | 1995 | ₹754 Cr (FY 2026) | Active | |
| Director | 02 Jul 2009 | 2009 | Strike Off | ||
| Director | 12 Jul 2004 | 2004 | ₹156 Cr (FY 2024) | Active | |
| Director | 26 Dec 2008 | 2008 | Strike Off | ||
| Director | 25 Mar 2009 | 2009 | Active | ||
| Director | 11 Jul 2009 | 2009 | Strike Off | ||
| Director | 28 Jan 2010 | 2010 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sundari Raviprasad Pisupati
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sundari Raviprasad Pisupati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sundari Raviprasad Pisupati
Sundari Raviprasad Pisupati currently holds 4 directorships: Eugia Pharma Specialities Limited (Director, since 01 Dec 2021, revenue ₹4,829 Cr (FY 2025)); Rainbow Children's Medicare Limited (Director, since 16 Sep 2021, revenue ₹1,567 Cr (FY 2025)); Rainbow Speciality Hospitals Private Limited (Director, since 25 May 2022, revenue ₹39.30 Cr (FY 2025)); Pratiksha Women & Child Care Hospital Private Limited (Director, since 18 Aug 2025).
Sundari Raviprasad Pisupati was first appointed on 12 Jul 2004 as Director at Quislex Legal Services Private Limited. The most recent appointment on record is 18 Aug 2025 at Pratiksha Women & Child Care Hospital Private Limited.
The 3 current companies of Sundari Raviprasad Pisupati that report revenue have a combined latest revenue of ₹6,435 Cr: Eugia Pharma Specialities Limited ₹4,829 Cr (FY 2025); Rainbow Children's Medicare Limited ₹1,567 Cr (FY 2025); Rainbow Speciality Hospitals Private Limited ₹39.30 Cr (FY 2025).
Sundari Raviprasad Pisupati held 9 earlier board appointments: Tran-Scell Biologics Private Limited (Director, 07 Dec 2009 to 11 Mar 2015); Ocean Sparkle Limited (Director, 07 Aug 2015 to 09 May 2022); Banyan & Zreyas Venture Advisors Private Limited (Director, 02 Jul 2009 to 01 Dec 2009); Quislex Legal Services Private Limited (Director, 12 Jul 2004 to 31 Mar 2008); Icool Information Technology Private Limited (Director, 26 Dec 2008 to 20 Dec 2012); and 4 more.
The current boards of Sundari Raviprasad Pisupati's companies include Madan Mohan Reddy Mettu (Eugia Pharma Specialities Limited), Ragunathan Kannan (Eugia Pharma Specialities Limited), Santhanam Subramanian (Eugia Pharma Specialities Limited), Vallamkondu Aravind Kumar (Eugia Pharma Specialities Limited), Veerayya Chowdary Kosaraju (Eugia Pharma Specialities Limited), Venkat Reddy Kupireddy (Eugia Pharma Specialities Limited), among others.